CDK4/6 inhibitors in breast cancer
Thank you for taking part
Thank you for completing this survey.
We hope you find the new content in this Learning Zone useful and that you follow our future updates. We may give you the opportunity to repeat the questionnaire you’ve just completed during a future visit to the Learning Zone to better understand how its content has influenced your understanding of this therapeutic area. Your answers will help us improve our educational materials on CDK4/6 inhibitors for breast cancer.